Page last updated: 2024-10-28

alverine and Abdominal Pain

alverine has been researched along with Abdominal Pain in 4 studies

alverine : A tertiary amine having one ethyl and two 3-phenylprop-1-yl groups attached to the nitrogen. An antispasmodic that acts directly on intestinal and uterine smooth muscle, it is used (particularly as the citrate salt) in the treatment of irritable bowel syndrome.

Abdominal Pain: Sensation of discomfort, distress, or agony in the abdominal region.

Research Excerpts

ExcerptRelevanceReference
"To evaluate the efficacy of alverine citrate and simeticone combination in patients with IBS-related abdominal pain/discomfort."9.14Clinical trial: the efficacy of alverine citrate/simeticone combination on abdominal pain/discomfort in irritable bowel syndrome--a randomized, double-blind, placebo-controlled study. ( Andro Delestrain, MC; Bueno, L; Ducrotté, P; Paradowski, L; Wittmann, T, 2010)
"To evaluate the efficacy of alverine citrate and simeticone combination in patients with IBS-related abdominal pain/discomfort."5.14Clinical trial: the efficacy of alverine citrate/simeticone combination on abdominal pain/discomfort in irritable bowel syndrome--a randomized, double-blind, placebo-controlled study. ( Andro Delestrain, MC; Bueno, L; Ducrotté, P; Paradowski, L; Wittmann, T, 2010)
"The severity and frequency of abdominal pain improved in 66% and 68% of patients treated with alverine citrate vs."5.10Alverine citrate fails to relieve the symptoms of irritable bowel syndrome: results of a double-blind, randomized, placebo-controlled trial. ( Chapman, RW; Mee, AS; Mitchell, SA; Palmer, KR; Smith, GD, 2002)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ducrotte, P2
Grimaud, JC1
Dapoigny, M1
Personnic, S1
O'Mahony, V1
Andro-Delestrain, MC1
Wittmann, T1
Paradowski, L1
Bueno, L1
Andro Delestrain, MC1
Ford, AC1
Mitchell, SA1
Mee, AS1
Smith, GD1
Palmer, KR1
Chapman, RW1

Clinical Trials (2)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Assessment of On-demand MeteoSpasmyl® Use Effectiveness in Irritable Bowel Syndrome[NCT01404923]Phase 4436 participants (Actual)Interventional2009-12-31Completed
The Role of Irritable Bowel Syndrome in Lactose Intolerance (LION Trial): Protocol of a Multicentre Randomized Controlled Clinical Trial[NCT05100719]200 participants (Anticipated)Interventional2022-09-30Not yet recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Change From Baseline in Irritable Bowel Syndrome Quality Of Life Overall Score

Irritable Bowel Syndrome Quality of Life total score (IBSQoL) is a health-related Quality of Life (QoL) disease-specific scale adapted for French patients. Total score ranges from minimum=0 to maximum = 100 representing the best outcome. (NCT01404923)
Timeframe: Baseline and 6 months

Interventionunits on a scale (Mean)
Meteospasmyl13.8
Standard of Care8.4

Percentage of Improvement of the Total IBSQoL Scores

Improvement of the total IBSQoL scores from baseline to month 6 calculated in percentage (NCT01404923)
Timeframe: Baseline and 6 Months

Intervention% of improvement of IBSQoL total scores (Mean)
Meteospasmyl28.5
Standard of Care18.6

Trials

3 trials available for alverine and Abdominal Pain

ArticleYear
On-demand treatment with alverine citrate/simeticone compared with standard treatments for irritable bowel syndrome: results of a randomised pragmatic study.
    International journal of clinical practice, 2014, Volume: 68, Issue:2

    Topics: Abdominal Pain; Antifoaming Agents; Double-Blind Method; Drug Combinations; Female; Humans; Irritabl

2014
On-demand treatment with alverine citrate/simeticone compared with standard treatments for irritable bowel syndrome: results of a randomised pragmatic study.
    International journal of clinical practice, 2014, Volume: 68, Issue:2

    Topics: Abdominal Pain; Antifoaming Agents; Double-Blind Method; Drug Combinations; Female; Humans; Irritabl

2014
On-demand treatment with alverine citrate/simeticone compared with standard treatments for irritable bowel syndrome: results of a randomised pragmatic study.
    International journal of clinical practice, 2014, Volume: 68, Issue:2

    Topics: Abdominal Pain; Antifoaming Agents; Double-Blind Method; Drug Combinations; Female; Humans; Irritabl

2014
On-demand treatment with alverine citrate/simeticone compared with standard treatments for irritable bowel syndrome: results of a randomised pragmatic study.
    International journal of clinical practice, 2014, Volume: 68, Issue:2

    Topics: Abdominal Pain; Antifoaming Agents; Double-Blind Method; Drug Combinations; Female; Humans; Irritabl

2014
Clinical trial: the efficacy of alverine citrate/simeticone combination on abdominal pain/discomfort in irritable bowel syndrome--a randomized, double-blind, placebo-controlled study.
    Alimentary pharmacology & therapeutics, 2010, Volume: 31, Issue:6

    Topics: Abdominal Pain; Adolescent; Adult; Aged; Antifoaming Agents; Double-Blind Method; Drug Combinations;

2010
Alverine citrate fails to relieve the symptoms of irritable bowel syndrome: results of a double-blind, randomized, placebo-controlled trial.
    Alimentary pharmacology & therapeutics, 2002, Volume: 16, Issue:6

    Topics: Abdomen; Abdominal Pain; Administration, Oral; Adult; Aged; Colonic Diseases, Functional; Double-Bli

2002

Other Studies

1 other study available for alverine and Abdominal Pain

ArticleYear
Alverine citrate, simeticone, and Rome III irritable bowel syndrome.
    Alimentary pharmacology & therapeutics, 2010, Volume: 31, Issue:7

    Topics: Abdominal Pain; Antifoaming Agents; Drug Therapy, Combination; Humans; Irritable Bowel Syndrome; Met

2010